Oral epithelial cell-derived human beta-defensins-1, -2, and -3 participate in innate immune responses against Candida. We hypothesized that these peptides utilize several mechanisms for protection. Recombinant hBD-1 and -2 were produced with the use of an insect cell/baculovirus expression system, while rhBD-3 was expressed as a fusion protein in E. coli. RhBD-2 and -3 were more effective at killing the candidal species at low micromolar concentrations than was rhBD-1, except for C. glabrata. While this species was relatively resistant to rhBD fungicidal activity, its adherence to oral epithelial cells was strain-specifically inhibited by the rhBDs. C. albicans hyphae were important in regulating hBD2 and -3 mRNA expression in primary human oral epithelial cells. Confocal microscopy of rhBD-2-challenged C. albicans suggests disruption of the fungal membrane. Results support the hypothesis that hBDs control fungal colonization through hyphal induction, direct fungicidal activity, and inhibition of candidal adherence.
Get full access to this article
View all access options for this article.
References
1.
Cormack BP, Ghori N, Falkow S -1999-. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science285:578–582.
2.
Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, et al. -2000-. Human keratinocytes that express hTERT and also bypass a p16-INK4a--enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol20:1436–1447.
3.
Edgerton M, Koshlukova SE, Araujo MW, Patel RC, Dong J, Bruenn JA -2000-. Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother44:3310–3316.
4.
Feucht E, DeSanti CL, Weinberg A -2003-. Selective induction of human beta-defensin mRNAs by Actinobacillus actinomycetemcomitans in primary and immortalized oral epithelial cells. Oral Microbiol Immunol18:1–5.
5.
Fidel PL Jr -2002-. Immunity to candida. Oral Dis8-Suppl 2-:69–75.
6.
Folwaczny C, Glas J, Torok HP -2003-. Crohn’s disease: an immunodeficiency? Eur J Gastroenterol Hepatol15:621–626.
7.
Ghannoum MA, Radwan SS -1990-. Candida adherence to epithelial cells. Boca Raton, FL: CRC Press.
8.
Gillum AM, Tsay EY, Kirsch DR -1984-. Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet198:179–182.
9.
Gorter AD, Oostrik J, van der Ley P, Hiemstra PS, Dankert J, van Alphen L -2003-. Involvement of lipooligosaccharides of Haemophilus influenzae and Neisseria meningitidis in defensin-enhanced bacterial adherence to epithelial cells. Microb Pathog34:121–130.
10.
Härder J, Bartels J, Christophers E, Schroder JM -1997-. A peptide antibiotic from human skin. Nature387:861.
11.
Härder J, Bartels J, Christophers E, Schroder JM -2001-. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem276:5707–5713.
12.
Hoover DM, Wu Z, Tucker K, Lu W, Lubkowski J -2003-. Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother47:2804–2809.
13.
Huppert M, Harper G, Sun SH, Delanerolle V -1975-. Rapid methods for identification of yeasts. J Clin Microbiol2:21–34.
14.
Joly S, Maze C, McCray PB Jr, Guthmiller JM -2004-. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol42:1024–1029.
15.
Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA -2003-. Single-nucleotide polymorphisms -SNPs- in human beta-defensin 1: high-throughput SNP assays and association with candida carriage in type 1 diabetics and nondiabetic controls. J Clin Microbiol41:90–96.
16.
Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA -1998-. Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun66:4222–4228.
17.
Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA -2000-. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun68:2907–2915.
18.
Li XS, Reddy MS, Baev D, Edgerton M -2003-. Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J Biol Chem278:28553–28561.
19.
Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR -1997-. Nonfilamentous C. albicans mutants are avirulent. Cell90:939–949.
20.
Mandel ID -1972-. Saliva. St. Louis: C.V. Mosby Co.
21.
Nikawa H, Jin C, Fukushima H, Makihira S, Hamada T -2001-. Antifungal activity of histatin-5 against non-albicans Candida species. Oral Microbiol Immunol16:250–252.
22.
Niyonsaba F, Ogawa H, Nagaoka I -2004-. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology111:273–281.
23.
Pankhurst C -2002-. Oropharyngeal candidiasis. Clin Evid7:1248–1262.
24.
Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, et al. -2003-. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS17:F39–F48.
25.
Redding SW, Dahiya MC, Kirkpatrick WR, Coco BJ, Patterson TF, Fothergill AW, et al. -2004-. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod97:47–52.
26.
Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, Sugahara T -2002-. High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res22:2103–2107.
27.
Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray PB Jr, et al. -2002-. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus.J Biol Chem277:8279–8289.
28.
Thevissen K, Warnecke DC, Francois IE, Leipelt M, Heinz E, Ott C, et al. -2004-. Defensins from insects and plants interact with fungal glucosylceramides. J Biol Chem279:3900–3905.
29.
Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T -1998-. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest101:1633–1642.
30.
Weinberg A, Krisanaprakornkit S, Dale BA -1998-. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med9:399–414.
31.
Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. -1999-. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 [see comments]. Science286:525–528.
